Subclinical skeletal muscle abnormalities in patients with hypertrophic cardiomyopathy and their relation to clinical characteristics

International Journal of Cardiology

Volumn 89, Issue 2-3, 2003, Pages 249-256

  Anastasakis, Aris ^a   Karandreas, Nikos ^b   Stathis, Pantelis ^c   Rigopoulos, Angelos ^a   Theopistou, Artemisia ^a   Sepp, Robert ^d   Elliott, Perry M ^e   Panagiotakos, Demosthenes B ^a   Stefanadis, Christodoulos ^a   Toutouzas, Pavlos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c First Hospital of Social Services Institution   (Greece)

^d UNIVERSITY OF SZEGED   (Hungary)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Electromyography; Hypertrophic cardiomyopathy; Skeletal muscle

Indexed keywords

TROPONIN T;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DELTOID MUSCLE; ELECTROMYOGRAM; FAMILY HISTORY; FEMALE; GENE MUTATION; GENOTYPE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MUSCLE MASS; MUSCLE WEAKNESS; MYOPATHY; PREVALENCE; PRIORITY JOURNAL; SKELETAL MUSCLE; SOLEUS MUSCLE; SUDDEN DEATH; SYNCOPE; TIBIALIS ANTERIOR MUSCLE; VASTUS LATERALIS MUSCLE;

EID: 0037722719     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00481-3     Document Type: Article

References (43)

1. Frank S., Braunwald E. Idiopathic hypertrophic subaortic stenosis: clinical analysis of 126 patients with emphasis on the natural history. Circulation. 37:1968;759-788.
2. Maron BJ, Bonow RO, Cannon RO III et al. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. New Engl J Med 1987;316:780-89, 844-52.
3. Wigle E.D., Rakowski H., Kimball B.P., et al. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation. 92:1995;1680-1692.
4. Bonne G., Carrier L., Richard P., et al. Familial hypertrophic cardiomyopathy. From mutations to functional defects. Circ. Res. 83:1998;580-593.
5. Hootsmans W.J.M., Meerschwam I.S. Electromyography in patients with hypertrophic obstructive cardiomyopathy. Neurology. 21:1971;810-816.
6. Shafiq S.A., Sande M.A., Carruthers R.R., et al. Skeletal muscle in idiopathic cardiomyopathy. J. Neurol. Sci. 15:1972;303-320.
7. Smith E.R., Heffernan L.P., Sangalang V.E., et al. Voluntary muscle involvement in hypertrophic cardiomyopathy. Ann. Intern. Med. 85:1976;566-572.
8. Caforio A.L.P., Rossi B., Risaliti R., et al. Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: evidence of subclinical myogenic myopathy. J. Am. Coll. Cardiol. 14:1989;1464-1473.
9. Karandreas N., Stathis P., Anastasakis A., et al. Electromyographic evidence of subclinical myopathy in hypertrophic cardiomyopathy. Muscle Nerve. 23:2000;1856-1861.
10. Kyriakidis M., Triposkiadis F., Anastasakis A., et al. Hypertrophic cardiomyopathy in Greece: clinical course and outcome. Chest. 114:1998;1091-1096.
11. McKenna W.J., Spirito P., Desnos M., et al. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart. 77:1997;130-132.
12. Elliott P.M., Poloniecki J., Dickie S., et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J. Am. Coll. Cardiol. 36:2000;2212-2218.
13. Johnson M.A., Polgar J., Weightman D., et al. Data on the distribution of fibre types in thirty-six human muscles: an autopsy study. J. Neurol. Sci. 18:1973;111-129.
14. Jandreski M.A., Sole M.J., Liew C.-C. Two different forms of beta myosin heavy chain are expressed in human striated muscle. Hum. Genet. 77:1987;127-131.
15. Mahdavi V., Izumo S., Nadal-Ginard B. Developmental and hormonal regulation of sarcomeric myosin heavy chain gene family. Circ. Res. 60:1987;804-814.
16. Buchtal F. Electromyography in the evaluation of muscle diseases. Neurol. Clin. 3:1985;573-598.
17. Gilchrist J.M., Nandedkar S.D., Stewart C.S., Massey G.M., Sanders D.B., Barkhaus P.E. Automatic analysis of the electromyographic interference pattern using the turns:amplitude ratio. Electroencephalogr. Clin. Electrophysiol. 70:1988;534-540.
18. Fuglsank-Frederiksen A., Ronager J. EMG power spectrum, turns-amplitude analysis and motor unit potential duration in neuromuscular disorders. J. Neurol. Sci. 97:1990;81-91.
19. Stalberg E., Bischoff C., Falck B. Outliers, a way to detect abnormality in quantitative EMG. Muscle Nerve. 17:1994;392-399.
20. Warmolts J.R., Engel W.K. Open-biopsy electromyography: I. Correlation of motor unit behavior with histochemical muscle fiber type in human limb muscle. Arch. Neurol. 27:1972;512-517.
21. Lipkin D.P., Jones D.A., Round J.M., et al. Abnormalities of skeletal muscle in patients with chronic heart failure. Int. J. Cardiol. 18:1988;309-315.
22. Engel W.K. Selective and non-selective susceptibility of muscle fiber types. Arch. Neurol. 22:1970;97-117.
23. Dubowitz V. Histochemical aspects of muscle disease. Walton J. Disorders of voluntary muscle. 1981;261-295 Churchill Livingstone, New York.
24. Clyne C.A.C., Mears H., Weller R.O., et al. Calf muscle adaptation to peripheral vascular disease. Cardiovasc. Res. 19:1985;507-512.
25. Fananapazir L., Dalakas M.C., Cyran F., et al. Missense mutations in the β-myosin heavy chain gene cause central core disease in hypertrophic cardiomyopathy. Proc. Natl. Acad. Sci. 90:1993;3993-3997.
26. Bradley W.G., Jones M.Z., Mussini J.M., Fawcett P.R.W. Becker type muscular dystrophy. Muscle Nerve. 1:1978;111-132.
27. Finsterer J., Mamoli B. Turn/amplitude-analysis in subclinical myogenic lesions. Acta Neurol. Scand. 96:1997;46-51.
28. Roses A.D., Roses M.J., Metcalf B.S., et al. Pedigree testing in Duchenne muscular dystrophy. Ann. Neurol. 2:1977;271-278.
29. Spirito P., Bellone P., Harris K.M., et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. New Engl. J. Med. 342:2000;1778-1785.
30. Yu Q.-T., Ifegwu J., Marian A.J., et al. Hypertrophic cardiomyopathy mutation is expressed in messenger RNA of skeletal as well as cardiac muscle. Circulation. 87:1993;406-412.
31. Cuda G., Fananapazir L., Zhu W.-S., et al. Skeletal muscle expression and abnormal function of β-myosin in hypertrophic cardiomyopathy. J. Clin. Invest. 91:1993;2861-2865.
32. Lankford E.B., Epstein N.D., Fananapazir L., et al. Abnormal contractile properties of muscle fibers expressing β-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J. Clin. Invest. 95:1995;1409-1414.
33. Anderson P.A.W., Greig A., Mark T.M., et al. Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart. Circ. Res. 76:1995;681-686.
34. Anderson P.A.W., Malouf N.N., Oakeley A.E., et al. Troponin T isoform expression in humans: a comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle. Circ. Res. 69:1991;1226-1233.
35. Malouf N.N., McMahon D., Oakeley A.E., et al. A cardiac troponin T epitope conserved across phyla. J. Biol. Chem. 267:1992;9269-9274.
36. Gautel M., Furst D.O., Cocco A., et al. Isoform transitions of the myosin binding protein C family in developing human and mouse muscles: lack of isoform transcomplementation in cardiac muscle. Circ. Res. 82:1998;124-129.
37. Fougerousse F., Delezoide A.-L., Fiszman M.Y., et al. Cardiac myosin binding protein C gene is specifically expressed in heart during murine and human development. Circ. Res. 82:1998;130-133.
38. Maron B.J., Moller J.H., Seidman C.E., et al. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. Circulation. 98:1998;1460-1471.
39. Marian A.J., Roberts R. Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers of sudden cardiac death. J. Cardiovasc. Electrophysiol. 9:1998;88-99.
40. Moolman J.C., Corfield V.A., Posen B., et al. Sudden death due to troponin T mutations. J. Am. Coll. Cardiol. 29:1997;549-555.
41. Niimura H., Bachinski L.L., Sangwatanaroj S., et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. New Engl. J. Med. 338:1998;1248-1257.
42. Charron P., Dubourg O., Desnos M., et al. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation. 97:1998;2230-2236.
43. Ackerman M.J., Ommen S.R., Van Driest S.L., et al. Malignant mutations in hypertrophic cardiomyopathy: a rare find indeed (abstract). J. Am. Coll. Cardiol. 37:(suppl A):2001;208A.